# Regional homogeneity alterations reflect pain and emotional dysregulation in adenomyosis

**Authors:** Wenjiang Wei, Yanying Chen, Kelei Hua, Bin Xia, Rujin Li, Weizhao Lin, Zichao Chen, Wenqing Xiao, Kanghui Yu, Yi Yin, Shoujun Xu, Yunfan Wu

PMC · DOI: 10.1080/07853890.2026.2620857 · Annals of Medicine · 2026-01-30

## TL;DR

The study finds that brain activity changes in specific regions are linked to pain and emotional issues in women with adenomyosis.

## Contribution

This study identifies specific brain regions with altered regional homogeneity in adenomyosis patients, linking them to pain severity and emotional dysregulation.

## Key findings

- AMD patients showed increased regional homogeneity in the right fusiform gyrus and decreased in bilateral supramarginal gyri.
- Abnormal brain activity in the right fusiform gyrus correlated with higher pain severity and anxiety scores.
- Regions like the right hippocampus and cerebellum were also associated with anxiety and depression symptoms.

## Abstract

Adenomyosis (AM) with dysmenorrhea (AMD) is a global public health concern that may involve abnormal brain function and heightened vulnerability to anxiety and depression. This study aimed to investigate static and dynamic regional homogeneity (sReHo and dReHo) alterations in AMD and their associations with clinical symptoms.

Fifty-two patients with AMD and 52 age- and education-matched healthy controls (HCs) underwent resting-state functional magnetic resonance imaging (rs-MRI). sReHo and dReHo maps were generated and compared using two-sample t-tests (voxel-level p < 0.01; cluster-level, Gaussian random field corrected p < 0.05), with age, education and head motion as covariates. Effect sizes (Cohen’s d) were calculated for significant clusters. Partial correlation analyses assessed relationships between regional homogeneity (ReHo) alterations and clinical measures, controlling for medication use, menstrual phase and psychiatric history.

Compared with HCs, AMD patients showed significantly increased sReHo and dReHo in the right fusiform gyrus (FFG; d = 0.84, p < 0.001) and decreased values in the bilateral supramarginal gyri (SMG; d = −0.73, p < 0.001). Additional regiongs exhibiting abnormal dReHo were included the bilateral angular gyri, right hippocampus, right cerebellum (lobule 4_5) , left middle frontal gyrus (MFG) and multiple subdivisions of the inferior frontal gyrus. Importantly, ReHo in the right FFG positively correlated with pain severity (visual analogue scale (VAS): r = 0.539-0.797, p < 0.001) and anxiety (Hamilton Anxiety Scale (HAMA): r = 0.442, p = 0.001). Abnormalities in the right hippocampus and cerebellum were also significantly associated with anxiety and depression scores (r = 0.555–0.861, all p < 0.001).

AMD is characterized by altered intrinsic brain activity in pain- and emotion-related regions, supporting a central mechanism underlying chronic pain and affective symptoms. These findings provide neuroimaging evidence for AMD-related brain dysfunction. Longitudinal studies with larger cohorts and hormonal control are warranted to confirm these results and clarify causal relationships.

## Linked entities

- **Diseases:** adenomyosis (MONDO:0010888), dysmenorrhea (MONDO:1060205), anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Genes:** MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, ANG (angiogenin) [NCBI Gene 283] {aka ALS9, HEL168, RAA1, RNASE4, RNASE5}
- **Diseases:** artery embolization (MESH:D004617), chronic pain (MESH:D059350), alcohol or drug abuse (MESH:D019966), trigeminal neuralgia (MESH:D014277), low back pain (MESH:D017116), neuropathic pain (MESH:D009437), peripheral (MESH:D010523), pelvic organ diseases (MESH:D056887), pelvic pain (MESH:D017699), abnormal uterine bleeding (MESH:D014592), AMD (MESH:D006009), schizophrenia (MESH:D012559), brain trauma (MESH:D000070642), obstetric complications (MESH:D007744), myometrial hyperplasia (MESH:D006965), noise (MESH:D014012), recognition (MESH:D020238), Dysmenorrhea (MESH:D004412), neurological or psychiatric disorders (MESH:D001523), post-traumatic stress disorder (MESH:D013313), pain (MESH:D010146), abnormal brain function (MESH:D001927), AM (MESH:D062788), Parkinson's disease (MESH:D010300), migraine with aura (MESH:D020325), Anxiety (MESH:D001007), HC (MESH:D000067329), inflammation (MESH:D007249), pituitary gland diseases (MESH:D010900), HAMD (MESH:C538175), psychosis (MESH:D011618), chronic (MESH:D002908), Depression (MESH:D003866), headache (MESH:D006261), Alzheimer's disease (MESH:D000544), bipolar disorder (MESH:D001714), miscarriage (MESH:D000022), abdominal pain (MESH:D015746), sleep disturbances (MESH:D012893)
- **Chemicals:** dReHo (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862852/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862852/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862852/full.md

---
Source: https://tomesphere.com/paper/PMC12862852